CAMT Stock Analysis: Camtek | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 6.618m USD | 12M Return: 58.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 82.9M
EPS Trend: 96.6%
Qual. Beats: 0
Rev. Trend: 98.0%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Camtek Ltd. (NASDAQ: CAMT) is an Israel-based manufacturer of inspection and metrology equipment used in semiconductor fabrication and packaging. The company sells its systems globally, with a customer base spanning the United States, China, Korea, Europe, and the broader Asia Pacific region. It serves semiconductor manufacturers, outsourced semiconductor assembly and test (OSAT) providers, integrated device manufacturers (IDMs), and wafer-level packaging subcontractors. The inspection and metrology segment is a critical part of the semiconductor supply chain, as these tools are used to detect defects and verify dimensions at various stages of chip production, directly impacting yield and quality control.
Camteks product portfolio is organized around two main platforms. The Eagle family (including Eagle G5, Eagle-i/Plus, and Eagle-AP/Plus) and the Hawk platform target the advanced packaging market, an area that has gained prominence with the rise of 2.5D/3D packaging, chiplets, and high-bandwidth memory used in AI and high-performance computing applications. The Golden Eagle platform addresses standard panel-level inspection, while the MicroProf line (AP, DI, FE, FS, PT, MHU, TL, 200, and 300) covers wafer-level metrology, surface measurement, and material handling for the semiconductor, MEMS, sapphire, and LED industries.
The company was incorporated in 1987 and is headquartered in Migdal HaEmek, Israel. Listed on NASDAQ since 2000, Camtek is classified within the Information Technology sector under the Semiconductor Materials & Equipment sub-industry, reflecting its role as a specialized equipment vendor to chip producers rather than a chip designer or fab operator itself.
- HBM and AI chip demand lifts advanced packaging metrology orders
- China revenue concentration exposes stock to export control risk
- Semiconductor capex recovery drives inspection equipment backlog growth
| Net Income: 48.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -11.28 > 1.0 |
| NWC/Revenue: 165.3% < 20% (prev 121.2%; Δ 44.18% < -1%) |
| CFO/TA 0.11 > 3% & CFO 141.9m > Net Income 48.1m |
| Net Debt (-171.5m) to EBITDA (134.5m): -1.27 < 3 |
| Current Ratio: 8.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (51.5m) vs 12m ago 4.43% < -2% |
| Gross Margin: 50.23% > 18% (prev 50.08%; Δ 0.15% > 0.5%) |
| Asset Turnover: 44.72% > 50% (prev 48.27%; Δ -3.55% > 0%) |
| Interest Coverage Ratio: 74.14 > 6 (EBIT TTM 122.8m / Interest Expense TTM 1.66m) |
| A: 0.64 (Total Current Assets 937.5m - Total Current Liabilities 112.3m) / Total Assets 1.30b |
| B: 0.32 (Retained Earnings 418.2m / Total Assets 1.30b) |
| C: 0.11 (EBIT TTM 122.8m / Avg Total Assets 1.12b) |
| D: 1.11 (Book Value of Equity 682.5m / Total Liabilities 615.5m) |
| Altman-Z'' = 7.12 = AAA |
| DSRI: 1.19 (Receivables 131.7m/100.4m, Revenue 499.1m/450.9m) |
| GMI: 1.00 (GM 50.08% / 50.23%) |
| AQI: 1.03 (AQ_t 0.23 / AQ_t-1 0.22) |
| SGI: 1.11 (Revenue 499.1m / 450.9m) |
| TATA: -0.07 (NI 48.1m - CFO 141.9m) / TA 1.30b) |
| Beneish M = -2.79 (Cap -4..+1) = A |
As of July 09, 2026, the stock is trading at USD 140.05 with a total of 770,191 shares traded. Over the past week, the price has changed by -14.14%, over one month by -16.97%, over three months by -17.66% and over the past year by +58.55%.
Current recommended Stop Loss: 115.60 (which is 17.5% or 1.8 ATR below the current price).
Camtek has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CAMT.
- StrongBuy: 5
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 187.3 | 33.7% |
P/E Trailing = 146.2268
P/E Forward = 40.9836
P/S = 13.2596
P/B = 9.7308
P/EG = 2.9302
Revenue TTM = 499.1m USD
EBIT TTM = 122.8m USD
EBITDA TTM = 134.5m USD
Long Term Debt = 487.8m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 498.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 11.0m
Net Debt = -171.5m USD (calculated: Debt 498.8m - CCE 670.3m)
Enterprise Value = 6.45b USD (6.62b + Debt 498.8m - CCE 670.3m)
Interest Coverage Ratio = 74.14 (Ebit TTM 122.8m / Interest Expense TTM 1.66m)
EV/FCF = 122.5x (Enterprise Value 6.45b / FCF TTM 52.6m)
FCF Yield = 0.82% (FCF TTM 52.6m / Enterprise Value 6.45b)
FCF Margin = 10.54% (FCF TTM 52.6m / Revenue TTM 499.1m)
Net Margin = 9.63% (Net Income TTM 48.1m / Revenue TTM 499.1m)
Gross Margin = 50.23% ((Revenue TTM 499.1m - Cost of Revenue TTM 248.4m) / Revenue TTM)
Gross Margin QoQ = 50.08% (prev 50.03%)
Tobins Q-Ratio = 4.97 (Enterprise Value 6.45b / Total Assets 1.30b)
Interest Expense / Debt = 0.33% (Interest Expense 1.66m / Debt 498.8m)
Taxrate = 3.15% (1.56m / 49.6m)
NOPAT = 118.9m (EBIT 122.8m * (1 - 3.15%))
Current Ratio = 6.40 (Total Current Assets 937.5m / Total Current Liabilities 146.6m)
Debt / Equity = 0.73 (Debt 498.8m / totalStockholderEquity, last quarter 682.5m)
Debt / EBITDA = -1.27 (Net Debt -171.5m / EBITDA 134.5m)
Debt / FCF = -3.26 (Net Debt -171.5m / FCF TTM 52.6m)
Total Stockholder Equity = 626.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.31% (Net Income 48.1m / Total Assets 1.30b)
RoE = 7.68% (Net Income TTM 48.1m / Total Stockholder Equity 626.0m)
RoCE = 11.02% (EBIT 122.8m / Capital Employed (Equity 626.0m + L.T.Debt 487.8m))
RoIC = 10.24% (NOPAT 118.9m / Invested Capital 1.16b)
WACC = 12.44% (E(6.62b)/V(7.12b) * Re(13.35%) + D(498.8m)/V(7.12b) * Rd(0.33%) * (1-Tc(0.03)))
Discount Rate = 13.35% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 46.67 | Cagr: 2.07%
[DCF] Terminal Value 59.49% ; FCFF base≈88.9m ; Y1≈77.9m ; Y5≈63.0m
[DCF] Fair Price = 16.69 (EV 607.4m - Net Debt -171.5m = Equity 778.9m / Shares 46.7m; r=12.44% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 96.61 | EPS CAGR: 24.58% | SUE: 0.72 | # QB: 0
Revenue Correlation: 97.96 | Revenue CAGR: 23.02% | SUE: 1.04 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.76 | Chg30d=+1.25% | Revisions=+22% | Analysts=12
EPS next Quarter (2026-09-30): EPS=0.93 | Chg30d=-0.52% | Revisions=-15% | Analysts=12
EPS current Year (2026-12-31): EPS=3.50 | Chg30d=+0.69% | Revisions=+18% | GrowthEPS=+7.5% | GrowthRev=+15.2%
EPS next Year (2027-12-31): EPS=4.52 | Chg30d=+3.78% | Revisions=+36% | GrowthEPS=+29.2% | GrowthRev=+22.2%
[Analyst] Revisions Ratio: +17% (up=19, down=13)